Anhui Fengyuan Pharmaceutical Co Ltd - Class A

SZSE:000153 (China)   Class A
Â¥ 5.06 (-0.59%) Sep 20
15.06
P/B:
1.21
Market Cap:
Â¥ 2.35B ($ 333.54M)
Enterprise V:
Â¥ 2.95B ($ 418.54M)
Volume:
3.55M
Avg Vol (2M):
5.32M
Trade In:
Volume:
3.55M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Anhui Fengyuan Pharmaceutical Co Ltd ( SZSE:000153 ) from 2000 to Sep 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Anhui Fengyuan Pharmaceutical stock (SZSE:000153) PE ratio as of Sep 22 2024 is 15.06. More Details

Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) PE Ratio (TTM) Chart

To

Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) PE Ratio (TTM) Historical Data

Total 1213
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Anhui Fengyuan Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-22 15.1 2024-07-18 15.6
2024-09-20 15.1 2024-07-17 15.4
2024-09-19 15.2 2024-07-16 15.5
2024-09-18 14.8 2024-07-15 15.7
2024-09-13 15.1 2024-07-12 16.1
2024-09-12 15.3 2024-07-11 16.1
2024-09-11 15.3 2024-07-10 15.4
2024-09-10 15.4 2024-07-09 15.7
2024-09-09 15.4 2024-07-08 15.5
2024-09-06 15.3 2024-07-05 16.1
2024-09-05 15.7 2024-07-04 15.6
2024-09-04 15.6 2024-07-03 16.1
2024-09-03 15.7 2024-07-02 16.3
2024-09-02 15.7 2024-07-01 16.3
2024-08-30 15.9 2024-06-28 16.0
2024-08-29 15.9 2024-06-27 15.5
2024-08-28 15.5 2024-06-26 15.9
2024-08-27 15.3 2024-06-25 15.4
2024-08-26 15.2 2024-06-24 15.1
2024-08-23 15.0 2024-06-21 15.8
2024-08-22 15.2 2024-06-20 15.7
2024-08-21 15.4 2024-06-19 15.9
2024-08-20 15.6 2024-06-18 16.1
2024-08-19 16.0 2024-06-17 16.1
2024-08-16 16.2 2024-06-14 16.1
2024-08-15 16.1 2024-06-13 16.2
2024-08-14 16.1 2024-06-12 16.7
2024-08-13 16.4 2024-06-11 16.4
2024-08-12 16.5 2024-06-07 16.3
2024-08-09 16.2 2024-06-06 16.0
2024-08-08 16.6 2024-06-05 16.6
2024-08-07 16.0 2024-06-04 17.1
2024-08-06 16.2 2024-06-03 17.1
2024-08-05 15.6 2024-05-31 17.7
2024-08-02 15.9 2024-05-30 17.6
2024-08-01 15.9 2024-05-29 17.6
2024-07-31 15.6 2024-05-28 17.5
2024-07-30 15.1 2024-05-27 18.0
2024-07-29 15.1 2024-05-24 18.0
2024-07-26 15.1 2024-05-23 17.9
2024-07-25 14.8 2024-05-22 18.3
2024-07-24 14.8 2024-05-21 18.3
2024-07-23 15.1 2024-05-20 18.3
2024-07-22 15.4 2024-05-17 18.0
2024-07-19 15.3 2024-05-16 18.0

Anhui Fengyuan Pharmaceutical Co Ltd (SZSE:000153) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Anhui Fengyuan Pharmaceutical Co Ltd operates in pharmaceutical research and development, production, and sales. The business of the company includes preparations, API, health care, and commercial logistics. The company is engaged in development of bio innovative drugs and in set up of drug distribution branches.